Korlym
Manufacturing · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.korlym.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Korlym
Corcept Therapeutics specializes in developing and providing treatments for endocrine disorders, particularly focusing on endogenous Cushing syndrome. Their primary product, Korlym® (mifepristone), is a once-daily oral medication designed to manage high blood sugar levels caused by excess cortisol in adults who cannot undergo surgery. The company offers personalized support through Corcept Cares, ensuring patients receive dedicated assistance throughout their treatment journey. Their target clients include adults with endogenous Cushing syndrome who also have type 2 diabetes mellitus or glucose intolerance.Explore more
Popular SearchesKorlymCorcept Therapeutics IncSIC Code 28,283NAICS Code 32,325Show moreSell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Korlym your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check out if Korlym is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Korlym
Product Launch: Get notified when Korlym launches new products
Click to see if Korlym had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Korlym has new funding data
Check if Korlym has recently received funding, and reach out quickly before it becomes old news!
Korlym, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Korlym recently announced quarterly report
Recommended Actions
Find VP level buyers at Korlym
Find 3 more new buyers
Compare Similar Companies to Korlym
Compare insights from companies similar to Korlym, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Company Profile Activity
Activity Insights
Korlym is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Korlym is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Korlym.
Korlym Tech Stack
A closer look at the technologies used by Korlym
Korlym News & Media
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Korlym
Sign Up For FreeTo access detailed company insights
Corcept Therapeutics specializes in developing and providing treatments for endocrine disorders, particularly focusing on endogenous Cushing syndrome. Their primary product, Korlym® (mifepristone), is a once-daily oral medication designed to manage high blood sugar levels caused by excess cortisol in adults who cannot undergo surgery. The company o... Read More
